Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
- $3.65 Billion
- Q4 2024
A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 2,547 shares of REGN stock, worth $1.62 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,547
Previous 2,073
22.87%
Holding current value
$1.62 Million
Previous $2.18 Million
16.75%
% of portfolio
0.05%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding REGN
# of Institutions
1,500Shares Held
86.6MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.89 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.48 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.06 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $68B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...